On 11/15/24, Emergent BioSolutions Inc (NYSE: EBS) stock suffered a major decline of -16.7%, closing at $7.72. Moreover, this decline was accompanied by unusually high trading volume at 178% of normal. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -29.8% during the last week.
Current PriceTarget Research Rating
Emergent BioSolutions has a current Value Trend Rating of A (Highest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Emergent BioSolutions has a very high Appreciation Score of 90 and a very high Power Rating of 98, with the Highest Value Trend Rating the result.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment